Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03086707 · ClinicalTrials.gov registry record · NA
Prefatory Study to Explore Changes in Nasal Mucociliary Clearance and to Standardize Nasal Scraping Procedure
A NA study, sponsored by Philip Morris Products S.A..
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03086707 is a NA study that has completed, run by Philip Morris Products S.A.. The registered enrollment target is 14 participants.
The verdict
NCT03086707, a NA study, has completed, sponsored by Philip Morris Products S.A..
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study intends to evaluate the nasal mucociliary clearance (NMC) by determining the value obtained for saccharin transit time (STT) test over the course of 12 hours following a single cigarette use in adult smokers, to compare it relative to never smokers, and to examine the relationship between plasma nicotine levels and STT value in smokers and never smokers. Safety will also be monitored during the study. The planned maximum study duration for a single study participant from Screening through completion of study will be 33 days.
Interventions
- OTHER Cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2017-01-21 |
| Est. Completion | 2017-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03086707
The ClinicalTrials.gov registry entry for NCT03086707 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philip Morris Products S.A., which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cigarette is the first listed.
NCT03086707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03086707 about?
NCT03086707 is a clinical study titled "Prefatory Study to Explore Changes in Nasal Mucociliary Clearance and to Standardize Nasal Scraping Procedure". This study intends to evaluate the nasal mucociliary clearance (NMC) by determining the value obtained for saccharin transit time (STT) test over the course of 12 hours following a single cigarette use in adult smokers, to compare it relative to never smokers, and to examine the relationship between...
What is the current status of trial NCT03086707?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2017-01-21. Estimated completion is 2017-09-29.
What interventions are being tested in trial NCT03086707?
The interventions under investigation include: Cigarette (OTHER).
Who is sponsoring clinical trial NCT03086707?
This trial is sponsored by Philip Morris Products S.A., which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.